ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 125 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,955 | -19.7% | 32,985 | +0.1% | 0.00% | – |
| Q2 2023 | $123,192 | +20.9% | 32,939 | +8.3% | 0.00% | – |
| Q1 2023 | $101,863 | -90.4% | 30,407 | -86.2% | 0.00% | -100.0% |
| Q4 2022 | $1,058,715 | -15.3% | 220,107 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $1,250,645 | -20.0% | 219,797 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $1,564,187 | -16.0% | 220,308 | -14.8% | 0.00% | 0.0% |
| Q1 2022 | $1,861,676 | -7.4% | 258,655 | +15.6% | 0.00% | 0.0% |
| Q4 2021 | $2,010,000 | -79.8% | 223,655 | -21.1% | 0.00% | -87.5% |
| Q3 2021 | $9,937,000 | +61.3% | 283,423 | -1.2% | 0.01% | +60.0% |
| Q2 2021 | $6,161,000 | -61.5% | 286,840 | +10.5% | 0.01% | -64.3% |
| Q1 2021 | $16,023,000 | +48.5% | 259,476 | +0.5% | 0.01% | +40.0% |
| Q4 2020 | $10,791,000 | – | 258,285 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |